However, this result might be caused by a small sample size in our cohort, as there was a clear trend toward better OS in the CDK19-negative group compared to CDK19-positive tumors.
← all excerpts
CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC.
1
—
—